| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Feb 20, 2025 | Neumora Therapeutics, Inc. | Head of R&D | Sell | 50.0 | -5,614 | -1.78% | ✓ | $9.4K |
| Oct 9, 2024 | Oct 11, 2024 | Neumora Therapeutics, Inc. | Head of R&D | Sell | 37.5 | -13,823 | -4.21% | ✓ | $208.1K |
| Sep 17, 2024 | Sep 19, 2024 | Neumora Therapeutics, Inc. | Head of R&D | Sell | 22.5 | -41,464 | -11.21% | ✓ | $492.8K |
| Sep 12, 2024 | Sep 16, 2024 | Neumora Therapeutics, Inc. | Head of R&D | Sell | 26.3 | -32,948 | -8.18% | ✓ | $376.7K |